Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @EMA_News
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EMA_News
-
To contribute to the global response to the outbreak of the novel
#coronavirus infections, EMA is taking concrete actions to accelerate the development and availability of medicinal products for the treatment and prevention of the new coronavirus:https://www.ema.europa.eu/en/news/ema-support-development-vaccines-treatments-novel-coronavirus …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EMA shares the
@EU_Commission priorities on improving#cancer prevention and care, and is committed to supporting the Commission and@Europarl_EN during the development of the future cancer plan.#EUCancerPlan#WorldCancerDay
@EU_Health.https://twitter.com/EU_Commission/status/1224595946505261056 …
0:50Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tutti dobbiamo assumere delle
ad un certo punto della nostra vita. Conosci il percorso di una medicina valutata dall'EMA? Dai un'occhiata alla brochure che spiega come una medicina arriva dal laboratorio al paziente, che è ora disponibile in italiano.
https://www.ema.europa.eu/en/documents/other/laboratory-patient-journey-centrally-authorised-medicine_it.pdf …pic.twitter.com/ZLCylSnRyA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Irgendwann müssen fast alle

einnehmen. Aber wie bewertet die EMA ob sie sicher sind und wirken? Eine neue Broschüre erklärt den Weg eines Arzneimittels vom Labor zum #patienten, jetzt auch auf Deutsch.
https://www.ema.europa.eu/en/documents/other/laboratory-patient-journey-centrally-authorised-medicine_de.pdf …pic.twitter.com/B90Q9JDeNs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nous devons tous prendre des

à un moment de notre vie. Savez-vous quel est le parcours emprunté par un médicament évalué par l’EMA ? Pour cela, lisez notre brochure expliquant comment un médicament va du laboratoire au #patient:
https://www.ema.europa.eu/en/documents/other/laboratory-patient-journey-centrally-authorised-medicine_fr.pdf …pic.twitter.com/bmTS8gGVnW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We gathered today to raise the EU flags in the lobby of EMA’s new and final building in Amsterdam: https://www.ema.europa.eu/en/news/eu-flags-are-emas-new-building-amsterdam …pic.twitter.com/1ZfD2G5P4E
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
UK withdrawal from the EU on 31 January 2020: During the transition period, EU pharmaceutical law will continue to be applicable to the UK, meaning that pharmaceutical companies can continue to carry out activities in the UK until the end of the year.
https://www.ema.europa.eu/en/news/uk-withdrawal-eu-31-january-2020 …pic.twitter.com/KwuQoHMBE8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First oral GLP-1 treatment for type 2
#diabetes recommended for approval. It provides patients with an option to treat the disease without injections https://www.ema.europa.eu/en/news/first-oral-glp-1-treatment-type-2-diabetes …#CHMPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First treatment for
#AcuteHepaticPorphyria, a rare life-threatening genetic condition, recommended for approval https://www.ema.europa.eu/en/news/first-treatment-acute-hepatic-porphyria …#CHMPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EMA’s human medicines committee (
#CHMP) recommends 15#medicines for approval at its January 2020 meeting: https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2020 …pic.twitter.com/xqCDIRAAYr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EU Medicines Agency proslijedio/la je Tweet
Join us for our
#WorldCancerDay
event next week at the @europarl_en. https://ec.europa.eu/health/non_communicable_diseases/events/ev_20200204_en … Find out what we are doing at the EU level to fight this disease
https://ec.europa.eu/health/non_communicable_diseases/cancer_en …
#EUCancerPlanpic.twitter.com/QdZ9G59jyw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we have published the key principles for the use of electronic product information (
#ePI4medicines) for EU medicines. Read what benefits ePI can deliver for#PublicHealth:
https://www.ema.europa.eu/en/news/key-principles-use-electronic-product-information-eu-medicines …pic.twitter.com/EJQABZCADZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you a
#veterinarian in the EU? You can now check EMA's updated scientific advice on the categorisation of antibiotics when prescribing these medicines for animals in your care:
https://www.ema.europa.eu/en/news/categorisation-antibiotics-used-animals-promotes-responsible-use-protect-public-animal-health …pic.twitter.com/8ldaAzsTa7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This week marks EMA’s 25th anniversary. Learn more about the key milestones and achievements in the authorisation and safety monitoring of
#medicines for human and animal use in the EU since EMA’s establishment in 1995:
https://www.ema.europa.eu/en/news/ema-celebrates-25-years-advancing-public-animal-health …
#25YearsEMApic.twitter.com/lcAthzXn4aHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What's on the agenda of the January meeting of EMA's human medicines committee https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-27-30-january-2020-meeting_en.pdf …
#CHMPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At its January meeting, EMA’s Committee for Advanced Therapies (CAT) re-elected Dr Martina Schüssler-Lenz as its chair, for a second three-year mandate. Congratulations!
https://www.ema.europa.eu/en/news/martina-schussler-lenz-re-elected-chair-committee-advanced-therapies …pic.twitter.com/IvvPPIQMuE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EU Medicines Agency proslijedio/la je Tweet
We welcome today's @EUCourtPress ruling confirming public access to clinical study trials.
judgement
https://europa.eu/!df47bT
We worked with @EMA_News over many years for greater transparency in this area
https://europa.eu/!VW63qU
https://europa.eu/!tv48ck pic.twitter.com/JuP22gXZo1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Court of Justice (
@EUCourtPress) upholds EMA’s approach to transparency:https://www.ema.europa.eu/en/news/court-justice-upholds-emas-approach-transparency …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Find out more about the top-ten recommendations of the HMA-EMA Joint
#BigData task force, which includes establishing an EU platform to access and analyse healthcare data from across the EU, called ‘DARWIN’.
https://www.ema.europa.eu/en/news/ten-recommendations-unlock-potential-big-data-public-health-eu …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The HMA-EMA Joint Big Data task force proposes ten priority actions to unlock the potential of big data for public health in the EU https://www.ema.europa.eu/en/news/ten-recommendations-unlock-potential-big-data-public-health-eu …pic.twitter.com/SCUEqx5nny
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.